Most research places the rate of detransition somewhere between 1% and 8%, though the real answer depends heavily on how “detransition” is defined and who is being counted. The broadest surveys, which include people who went back to living as their birth-assigned sex even temporarily, land around 8%. Studies that track only formal requests to reverse surgery or stop hormones out of regret find rates closer to 1–2%. That gap is not a contradiction; it reflects genuinely different questions being asked of genuinely different populations, and it sits at the center of one of the most politically charged debates in modern medicine.
Why the Numbers Vary So Much
The single biggest obstacle to a clean answer is that researchers do not agree on what counts as detransition. Some studies define it narrowly as expressing regret and requesting reversal treatment. Others count anyone who stopped hormones or reverted to their birth-assigned gender for any length of time, including people who paused and later resumed transition. Still others use prescription-refill databases, where someone who switches pharmacies or loses insurance looks the same as someone who quit deliberately. A 2024 critical review found that this inconsistency was the primary barrier to reliable prevalence estimates, noting that the lack of a shared definition “prevents comparisons between them.”1PubMed Central. Gender detransition: A critical review of the literature – Section: Results and Discussion A separate 2024 systematic review of hormonal detransition studies reached the same conclusion, finding that all included studies were too heterogeneous in definitions, too small, or too short in follow-up to yield statistically meaningful numbers.2PubMed. Prevalence of detransition in persons seeking gender-affirming hormonal treatments: a systematic review
This matters for the reader because almost any percentage you encounter in a headline is probably accurate under one definition and misleading under another. When the critical review broke numbers down by category, the ranges told the story plainly: detransition defined by expressed regret sat between 0% and about 13%, while discontinuation of medical treatment without necessarily regretting it ran from roughly 2% to 30%.3PubMed Central. Gender detransition: A critical review of the literature – Section: Results Someone can stop hormones because they moved, lost their job, or achieved the physical changes they wanted, and that gets counted as “discontinuation” in the same column as someone who genuinely reversed course. Stopping treatment and regretting transition are overlapping but distinct categories, and conflating them inflates the headline number.
The Largest Survey to Date
The most-cited figure comes from the 2015 U.S. Transgender Survey, a cross-sectional study of nearly 28,000 transgender adults. It asked a simple question: “Have you ever de-transitioned? In other words, have you ever gone back to living as your sex assigned at birth, at least for a while?” About 8% said yes, but the majority of those reported that the detransition was temporary. Rates were higher among transgender women (about 11%) than transgender men (about 4%).4PubMed Central. Detransition Among Transgender and Gender-Diverse People—An Increasing and Increasingly Complex Phenomenon
That 8% includes people who went back to living as their birth sex temporarily because of safety concerns, financial pressure, or family conflict, and who later resumed their transition. It is not a measure of permanent reversal or regret. The distinction is significant: a trans woman who presents as male at work to avoid harassment and then returns to living as female has technically “detransitioned” under this survey’s wording. Whether that belongs in the same bucket as someone who concluded their gender identity had changed is a judgment call the survey itself does not make.
Surgical Regret Rates
When the question narrows to people who have undergone gender-affirming surgery and later regret it, the numbers drop substantially. A 2021 systematic review and meta-analysis pooled data from multiple studies and found a regret prevalence of about 1%, with a slightly higher rate among those who had transfeminine procedures compared to transmasculine ones.5PubMed Central. Regret after Gender-affirmation Surgery: A Systematic Review and Meta-analysis of Prevalence A more recent 2024 systematic review placed the overall surgical regret rate at just under 2%, again with transfeminine regret (about 4%) running higher than transmasculine regret (under 1%).6PubMed. Prevalence of Regret in Gender-Affirming Surgery: A Systematic Review The slight increase between the two reviews likely reflects newer studies with longer follow-up periods being added to the pool, but both figures remain low by the standards of elective surgery generally.
For context, a 2024 review that compared regret across surgical specialties found that regret after breast reconstruction ranged from 0% to 47%, breast augmentation sat around 5–9%, and bariatric surgery reached up to about 20%. Regret after prostatectomy was about 30%. Against those benchmarks, gender-affirming surgery’s rate of roughly 1–2% is unusually low.7The American Journal of Surgery. Regret after gender-affirming surgery: A systematic review and meta-analysis That comparison does not mean the experiences of those who do regret surgery are trivial. But it does suggest that the screening and decision-making processes in gender-affirming care are, if anything, more conservative than those in many other areas of surgery.
Why People Detransition
This is where the research gets genuinely complicated, because two prominent studies point in different directions. A widely cited 2021 mixed-methods analysis of transgender and gender-diverse adults in the United States found that among those who had detransitioned, about 83% reported at least one external driving factor. The most frequently endorsed reasons were pressure from family and societal stigma. In that study, detransition was strongly associated with having an unsupportive family.8PubMed Central. Factors Leading to “Detransition” Among Transgender and Gender Diverse People in the United States: A Mixed-Methods Analysis
A 2024 study of previously trans-identified young adults told a different story. In that sample, external pressures like transphobia, family pressure, religion, and peer influence all received the lowest importance ratings as reasons for detransition. Participants instead emphasized internal factors.9PubMed Central. Detransition and Desistance Among Previously Trans-Identified Young Adults The two studies used different recruitment methods, different populations, and different frameworks for asking about motives, which likely explains much of the divergence. The first drew from a broad community sample where many participants had retransitioned (gone back to living as trans after a period of detransition), while the second specifically recruited young adults who no longer identified as transgender. Both findings can be true simultaneously for different groups of people. Someone who detransitions because of hostile family dynamics and someone who detransitions after concluding their gender identity shifted are having fundamentally different experiences, and lumping them together obscures more than it reveals.
The practical takeaway is that “why” someone detransitions matters as much as “how many.” Policies built on the assumption that detransition primarily reflects misdiagnosis would look very different from policies built on the understanding that it often reflects social hostility. The evidence suggests both pathways exist, and their relative proportions depend on the population studied.
Hormone Continuation and Discontinuation
Prescription-refill data offers another angle. A study tracking gender-affirming hormone prescriptions in a large U.S. health system found that about 70% of patients who started hormones continued filling prescriptions for at least four years. Transfeminine individuals had a higher four-year continuation rate (about 81%) than transmasculine individuals (about 64%). People who started hormones before age 18 were actually more likely to continue than those who started as adults.10The Journal of Clinical Endocrinology & Metabolism. Continuation of Gender-affirming Hormones Among Transgender Adolescents and Adults
That 30% who stopped within four years is sometimes cited as evidence of high detransition, but the figure is misleading without context. A systematic review of hormone continuation studies found that most reported discontinuation rates below 10%, with one outlier study reporting about 31% discontinuation or loss to follow-up.11PubMed. Continuation of Gender-Affirming Hormone Therapy in Transgender and Gender-Diverse Individuals: A Systematic Review “Loss to follow-up” is a known problem in this research: a person who moves to a different city and starts getting hormones from a new provider disappears from the original clinic’s records. A 2025 German study directly investigated this issue, following 709 adults who received gender-affirming care. About a third stopped attending the study clinic, which sounds alarming until you learn that over 94% of those people were found to have continued transitioning through community-based providers elsewhere. The actual detransition rate among people whose outcomes could be determined was under 2%.12International Journal of Transgender Health. Low detransition rates among 709 adult gender-affirming therapy recipients, motives and risk factors: Results from a systematic follow-up study
Nonbinary individuals add another wrinkle. A study of adolescents and young adults found that nonbinary identity was associated with higher rates of discontinuing hormone therapy, but the researchers suggested this may reflect nonbinary people intentionally using hormones for shorter periods to achieve specific, limited physical changes rather than a full medical transition.13Journal of Adolescent Health. Prevalence, Correlates, and Reasons for Discontinuing Gender-Affirming Medical Treatment Among Transgender and Gender-Diverse Adolescents and Young Adults A transmasculine nonbinary person who takes testosterone for a year to achieve a deeper voice and then stops has met their goals. Counting that as detransition mischaracterizes the experience.
Children and Adolescents
The question gets particularly charged when it involves young people. A five-year follow-up of 317 children who had socially transitioned (changing name, pronouns, and presentation, but no medical intervention) found that the overall retransition rate was about 7%. Most of those children shifted to a nonbinary identity rather than returning fully to their sex assigned at birth. Only about 2.5% were using pronouns associated with their birth sex at the end of the study.14Pediatrics. Gender Identity 5 Years After Social Transition Social transition in childhood is entirely reversible, involving no hormones or surgery, so the stakes differ fundamentally from medical interventions.
Among adolescents who did begin medical treatment, a 2024 study published in JAMA Pediatrics followed 220 youths receiving gender-affirming care. At the study’s endpoint, 97% were continuing treatment. About 4% expressed clear regret about at least one treatment they had received, but even among those, about half continued some form of gender-affirming care. Only four of the 220 had stopped care entirely.15JAMA Pediatrics. Levels of Satisfaction and Regret With Gender-Affirming Medical Care in Adolescence A UK gender identity clinic found an even lower rate: among roughly 300 patients reviewed at the Nottingham Centre for Transgender Health, only one case of detransition was identified, a rate of about 0.3%.16Counselling Psychology Review. Detransition rates in a large national gender identity clinic in the UK
The common claim that large numbers of gender-questioning children will “grow out of it” often conflates older studies of childhood gender nonconformity (which included many children who never met criteria for gender dysphoria) with modern cohorts of children who have persistently, clearly identified as transgender. The two populations behave differently, and applying desistance rates from the former to the latter overstates the risk.
Whether the Rates Are Changing
A legitimate open question is whether historical detransition rates will hold as the demographics of people seeking care shift. The number of people presenting for gender-affirming treatment has grown substantially, the proportion who are assigned female at birth has increased, and more people identify as nonbinary rather than binary transgender. An editorial in the Journal of Clinical Endocrinology and Metabolism noted that with more people accessing care through informed-consent models, and potentially fewer receiving thorough mental health evaluations beforehand, “it is quite possible that low reported rates of detransition and regret in previous populations will no longer apply to current populations.”4PubMed Central. Detransition Among Transgender and Gender-Diverse People—An Increasing and Increasingly Complex Phenomenon
This is not the same as saying rates will definitely rise. It is an acknowledgment that the evidence base is mostly built on cohorts from an era when access to care was more gatekept, and those cohorts may not represent today’s patient population. The responsible interpretation is that current rates are low, the trend could change, and monitoring matters. Anyone who asserts with confidence what the future rate will be, in either direction, is out ahead of the data.
Healthcare Gaps for People Who Detransition
Whatever the numbers turn out to be, people who do detransition face real and underserved medical needs. A 2022 study in JAMA Network Open found that medical detransition was often experienced as both physically and psychologically challenging. Healthcare avoidance was common among participants, who described encountering stigma and clinicians who were unprepared to address their detransition-related needs.17PubMed Central. Health Care Experiences of Patients Discontinuing or Reversing Prior Gender-Affirming Treatments Some felt alienated from both the transgender community and conventional medical settings, caught in a gap where neither side knew how to help.
A 2025 mixed-methods study echoed this, emphasizing that community-led care and affirming clinical approaches could reduce the distress associated with detransition and retransition experiences.18PubMed Central. “Providers had no idea what to do with me”: A mixed-methods analysis of detransition/retransition support, care, and information needs among sexual and gender minority individuals The political weaponization of detransition stories, where individual narratives are used to justify restricting care for all trans people, can make detransitioners reluctant to seek help from providers they fear will judge them, or from trans communities they worry about alienating. The irony is that better support for the small number who do detransition is entirely compatible with maintaining access to care for the large majority who do not.
Mental Health in Detransitioned Populations
Research on the mental health of people who detransition is still thin, but what exists paints a picture of a group that needs more support than it typically receives. A 2025 study examining adults with different gender trajectories found high rates of psychiatric diagnoses, psychopharmacological medication use, and self-reported mental health difficulties across the entire sample of transgender and gender-diverse people, including those who had detransitioned. Over half reported lifetime suicidal ideation, and more than 20% reported a history of suicide attempts.19PubMed Central. Sociodemographic and Mental Health Characteristics of Adults with Different Gender Trajectories
These numbers reflect both the general mental health burden that transgender and gender-diverse people carry, driven in large part by minority stress and social rejection, and the specific challenges that come with reversing a major life decision. Detransition does not necessarily mean someone’s mental health worsened because of transition. In many cases, pre-existing mental health conditions may have been factors in both the original transition and the subsequent detransition. Disentangling cause and effect in this population is genuinely difficult, and researchers have been honest about that limitation.
The Retransition Pattern
One aspect that rarely makes it into public debates is retransition: people who detransition and then transition again. The U.S. Transgender Survey data showed that most people who reported detransitioning did so only temporarily, eventually returning to a gender identity different from their birth-assigned sex. The children’s social-transition study similarly found that some young people cycled through identities, with a small number retransitioning twice, moving to nonbinary and then back to binary transgender. These trajectories suggest that gender identity can involve a process of exploration, particularly for young people, without that exploration being evidence that the underlying identity is invalid. A person who takes a winding path to the same destination has still arrived.
For clinicians, the retransition pattern argues for ongoing support rather than gatekeeping. A patient who detransitions temporarily because of family pressure and then retransitions when their circumstances change needs a healthcare system flexible enough to meet them wherever they are, not one that treats any deviation from a linear path as a failure of the original assessment. The evidence so far suggests that kind of flexible, nonjudgmental care is exactly what most people in this situation lack.